Results 201 to 210 of about 145,423 (282)

Nanoparticle‐Based Tolerogenic Vaccines: Next‐Generation Strategies for Autoimmune and Allergic Disease Therapies

Angewandte Chemie, Volume 138, Issue 6, 2 February 2026.
Nanoparticle‐based tolerogenic vaccines harness controlled antigen delivery and immunomodulation to establish tolerance in autoimmunity and allergy. This review outlines how nanoparticle design (size, shape, composition, administration route) influences biodistribution and immune‐cell targeting.
Benjamin E. Nachod, Ajay S. Thatte, Rohan Palanki, Michael J. Mitchell   +3 more
wiley   +2 more sources

Computational studies on rep and capsid proteins of CRESS DNA viruses. [PDF]

Virusdisease
Yadhav Y, Selvaraj K, Ramasamy S, Venkataraman S.   +3 more
europepmc   +1 more source

Dengue and Zika Virus Capsid Proteins Contain a Common PEX19-Binding Motif. [PDF]

Viruses, 2022
Farelo MA, Korrou-Karava D, Brooks KF, Russell TA, Maringer K, Mayerhofer PU.   +5 more
europepmc   +1 more source

In vivo and in vitro association of hsc70 with polyomavirus capsid proteins [PDF]

, 1995
Timothy P. Cripe, Sue E. Delos, Patricia A. Estes, Robert L. Garcea   +3 more
openalex   +1 more source

Gene therapy for epilepsy: An emerging, promising approach for a serious neurological disorder

Journal of Internal Medicine, Volume 299, Issue 3, Page 302-327, March 2026.
Abstract Gene therapy is emerging as a groundbreaking strategy for treating epilepsy, offering new hope to patients who do not respond to conventional medications. Despite advancements in anti‐seizure treatments, nearly 30%–40% of individuals with epilepsy continue to experience uncontrolled seizures, highlighting the urgent need for more effective and
Marco Ledri, Merab Kokaia
wiley   +1 more source

Out-of-sync evolutionary patterns and mutual interplay of major and minor capsid proteins in norovirus GII.2. [PDF]

J Gen Virol
Xu R, Xue L, Wang J, Chen Y, Cao Y, Gao J, Gao H, Du Q, Kou X, Yu L.   +9 more
europepmc   +1 more source

Low-molecular-weight anti-HIV-1 agents targeting HIV-1 capsid proteins. [PDF]

RSC Adv, 2023
Kobayakawa T, Yokoyama M, Tsuji K, Fujino M, Kurakami M, Onishi T, Boku S, Ishii T, Miura Y, Shinohara K, Kishihara Y, Ohashi N, Kotani O, Murakami T, Sato H, Tamamura H.   +15 more
europepmc   +1 more source

Characterization of Adeno-Associated Virus Capsid Proteins with Two Types of VP3-Related Components by Capillary Gel Electrophoresis and Mass Spectrometry

, 2021
Hiroaki Oyama, Kentaro Ishii, Takahiro Maruno, Tetsuo Torisu, Susumu Uchiyama   +4 more
openalex   +1 more source

Cell and Gene Therapy in Equine Ocular Disease

Veterinary Ophthalmology, Volume 29, Issue 2, March 2026.
ABSTRACT Equine ocular disease is common and often challenging to treat using traditional methods. This has led to the development of new therapies. Like human medicine, veterinary medicine is adopting cellular and gene therapy as innovative approaches. Equine ocular disease is a particularly promising area for these techniques.
Kimberly A. S. Young, Lauren V. Schnabel, Brian C. Gilger   +2 more
wiley   +1 more source

Immunoinformatics-driven design of a multi-epitope vaccine targeting neonatal rotavirus with focus on outer capsid proteins VP4 and VP7 and non structural proteins NSP2 and NSP5. [PDF]

Sci Rep
Sharma AD, Magdaleno JSL, Singh H, Orduz AFC, Cavallo L, Chawla M.   +5 more
europepmc   +1 more source